VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
83,458
AK1,737
AL5,895
AR3,823
AS44
AZ14,102
CA62,446
CO11,729
CT8,455
DC1,704
DE1,803
FL39,843
FM3
GA14,692
GU90
HI2,364
IA4,609
ID2,630
IL20,756
IN23,271
KS4,587
KY7,828
LA5,127
MA14,843
MD12,721
ME3,182
MH8
MI19,376
MN12,235
MO9,672
MP30
MS2,935
MT2,297
NC16,691
ND1,378
NE2,941
NH3,042
NJ18,815
NM3,969
NV4,440
NY35,179
OH19,431
OK6,301
OR8,578
PA24,187
PR2,311
QM2
RI2,028
SC6,647
SD1,195
TN9,559
TX37,124
UT4,319
VA14,940
VI54
VT1,749
WA14,881
WI11,147
WV2,359
WY869
XB5
XL1
XV2

ID: 1598466
Sex: M
Age: 45
State: CO

Vax Date: 03/22/2021
Onset Date: 03/23/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a and describes the occurrence of ILLNESS (got sick), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (he did not feel good), NASOPHARYNGITIS (cold) and PAIN IN EXTREMITY (under arm was sore) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced ILLNESS (got sick), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (he did not feel good), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (under arm was sore) and MYALGIA (body hurt). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (ALKA SELTZER PLUS AND FLU) at an unspecified dose and frequency. At the time of the report, ILLNESS (got sick), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (he did not feel good), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (under arm was sore) and MYALGIA (body hurt) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided/unknown by the reporter.

Other Meds:

Current Illness:

ID: 1598467
Sex: F
Age:
State: NV

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine given to the patient as she was 16 years old; A spontaneous report was received from a nurse, concerning a 16-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA -1273)/product administered to patient of inappropriate age. The patient's medical history as provided included COVID positive on 09 Feb 2021. Products known to have been used by the patient, within two weeks prior to the event included benzoyl peroxide 5% topical cleanser. On 18 Feb 2021 at 03:30 pm, the patient received their first of two planned doses of mRNA-1273 (Batch number: 016M20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection considered as product administered to patient of inappropriate age. It was reported that the patient was doing well with no signs and symptoms. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not provided. The outcome of the event Moderna vaccine given to the patient when she was 16 years old/ product administered to patient of inappropriate age was considered as resolved on 18 Feb 2021.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age, for mRNA-1273, lot #: 016M20A, with no associated AEs.

Other Meds: BENZOYL PEROXIDE

Current Illness:

ID: 1598468
Sex: F
Age:
State: AZ

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: assistant was out of the office for three to four days after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (assistant was out of the office for three to four days after the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced VACCINATION COMPLICATION (assistant was out of the office for three to four days after the vaccine). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (assistant was out of the office for three to four days after the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. From the first dose she just had a sore arm later in the evening

Other Meds:

Current Illness:

ID: 1598469
Sex: F
Age: 57
State: NJ

Vax Date: 02/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm is swollen and red under the armpit; Gland around her neck is swollen; Weakness; like she has the flu; Pain throughout her body; Arm is swollen and red under the armpit; fever is 100.9 ? F; Tired; Chills; Nausea in her stomach/nausea every time she eats; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Arm is swollen and red under the armpit), LYMPHADENOPATHY (Gland around her neck is swollen), ASTHENIA (Weakness), INFLUENZA LIKE ILLNESS (like she has the flu) and CHILLS (Chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included CLARITHROMYCIN for Allergy. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced CHILLS (Chills) and NAUSEA (Nausea in her stomach/nausea every time she eats). On 24-Mar-2021, the patient experienced LYMPHADENOPATHY (Arm is swollen and red under the armpit), LYMPHADENOPATHY (Gland around her neck is swollen), ASTHENIA (Weakness), INFLUENZA LIKE ILLNESS (like she has the flu), MYALGIA (Pain throughout her body), ERYTHEMA (Arm is swollen and red under the armpit), PYREXIA (fever is 100.9 ? F) and FATIGUE (Tired). At the time of the report, LYMPHADENOPATHY (Arm is swollen and red under the armpit), LYMPHADENOPATHY (Gland around her neck is swollen), ASTHENIA (Weakness), INFLUENZA LIKE ILLNESS (like she has the flu), CHILLS (Chills), NAUSEA (Nausea in her stomach/nausea every time she eats), MYALGIA (Pain throughout her body), ERYTHEMA (Arm is swollen and red under the armpit), PYREXIA (fever is 100.9 ? F) and FATIGUE (Tired) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Body temperature: 100.9 ? f High. Treatment information was not provided. /unknown.

Other Meds: CLARITHROMYCIN

Current Illness:

ID: 1598470
Sex: F
Age: 47
State: NC

Vax Date: 03/05/2021
Onset Date: 03/06/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Brain fog; Loss appetite; Pain in injection site (right); Fatigue; Chills; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog), DECREASED APPETITE (Loss appetite), VACCINATION SITE PAIN (Pain in injection site (right)), FATIGUE (Fatigue) and CHILLS (Chills) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and CALCIPOTRIOL (DOVONEX) for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (Brain fog), DECREASED APPETITE (Loss appetite), VACCINATION SITE PAIN (Pain in injection site (right)), FATIGUE (Fatigue), CHILLS (Chills) and ARTHRALGIA (Joint pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 06-Mar-2021 at a dose of 2 doses. On 07-Mar-2021, FEELING ABNORMAL (Brain fog), DECREASED APPETITE (Loss appetite), VACCINATION SITE PAIN (Pain in injection site (right)), FATIGUE (Fatigue) and ARTHRALGIA (Joint pain) had resolved. On 09-Mar-2021, CHILLS (Chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient was recommended for second dose on 30 March 2021. Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Added concomitant medication and amended narrative.

Other Meds: ZOLOFT; DOVONEX

Current Illness:

ID: 1598471
Sex: F
Age: 62
State: FL

Vax Date: 03/13/2021
Onset Date: 03/20/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mark is hot and warm to the touch; mark is now spreading into a round red spot / got the mark again after it cleared; Covid-arm; hard round lump in her arm; red dot at or near injection site; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Covid-arm), INJECTION SITE MASS (hard round lump in her arm), INJECTION SITE DISCOLOURATION (red dot at or near injection site), INJECTION SITE WARMTH (mark is hot and warm to the touch) and INJECTION SITE ERYTHEMA (mark is now spreading into a round red spot / got the mark again after it cleared) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Covid-arm) and INJECTION SITE DISCOLOURATION (red dot at or near injection site). 20-Mar-2021, the patient experienced INJECTION SITE MASS (hard round lump in her arm). On an unknown date, the patient experienced INJECTION SITE WARMTH (mark is hot and warm to the touch) and INJECTION SITE ERYTHEMA (mark is now spreading into a round red spot / got the mark again after it cleared). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Covid-arm), INJECTION SITE WARMTH (mark is hot and warm to the touch) and INJECTION SITE ERYTHEMA (mark is now spreading into a round red spot / got the mark again after it cleared) outcome was unknown and INJECTION SITE MASS (hard round lump in her arm) and INJECTION SITE DISCOLOURATION (red dot at or near injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant and treatment medications were reported.

Other Meds:

Current Illness:

ID: 1598472
Sex: M
Age: 79
State: MO

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: stability problems; vertigo; tingling; chills; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (stability problems), VERTIGO (vertigo), PARAESTHESIA (tingling) and CHILLS (chills) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included No adverse reaction. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced BALANCE DISORDER (stability problems), VERTIGO (vertigo), PARAESTHESIA (tingling) and CHILLS (chills). At the time of the report, BALANCE DISORDER (stability problems), VERTIGO (vertigo), PARAESTHESIA (tingling) and CHILLS (chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment was reported. Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: NNI, Per reporter - "You will have to make it easier to send back. We couldn't return it". On 15-Jul-2021: Significant follow up received on 15-JUL-2021. Patient updated the outcome as resolved by stating 'No symptoms remain'.

Other Meds: ASPIRIN (E.C.)

Current Illness:

ID: 1598473
Sex: F
Age: 68
State: AR

Vax Date: 03/09/2021
Onset Date: 03/22/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: it also feels warm; Arm turned really red on the injection site, the size of my hand; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (it also feels warm) and VACCINATION SITE ERYTHEMA (Arm turned really red on the injection site, the size of my hand) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. (1 or 0) 27A21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced FEELING HOT (it also feels warm) and VACCINATION SITE ERYTHEMA (Arm turned really red on the injection site, the size of my hand). At the time of the report, FEELING HOT (it also feels warm) and VACCINATION SITE ERYTHEMA (Arm turned really red on the injection site, the size of my hand) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported Treatment using anti itch cream was reported

Other Meds:

Current Illness:

ID: 1598474
Sex: F
Age:
State: SC

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Received a third dose of the vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXTRA DOSE ADMINISTERED (Received a third dose of the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). On 20-Mar-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced EXTRA DOSE ADMINISTERED (Received a third dose of the vaccine). On 20-Mar-2021, EXTRA DOSE ADMINISTERED (Received a third dose of the vaccine) had resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This report refers to a case of Extra dose administered for mRNA-1273 (Lot number: Unknown) with no associated AEs.; Sender's Comments: This report refers to a case of Extra dose administered for mRNA-1273 (Lot number: Unknown) with no associated AEs.

Other Meds:

Current Illness:

ID: 1598475
Sex: F
Age: 93
State: CT

Vax Date: 03/08/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: face was swollen on both side; swelling in her upper lip.; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face was swollen on both side) and LIP SWELLING (swelling in her upper lip.) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (face was swollen on both side) and LIP SWELLING (swelling in her upper lip.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, SWELLING FACE (face was swollen on both side) and LIP SWELLING (swelling in her upper lip.) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported.

Other Meds:

Current Illness:

ID: 1598476
Sex: F
Age: 89
State: MI

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on her face got really bad; Swelling of her whole face after the second dose; Redness on her whole face after the second dose; Itching on her whole face after the second dose; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), SWELLING FACE (Swelling of her whole face after the second dose), ERYTHEMA (Redness on her whole face after the second dose), PRURITUS (Itching on her whole face after the second dose) and RASH (Rash on her face got really bad) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. No Medical History information was reported. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced FATIGUE (Fatigue). On 19-Mar-2021, the patient experienced SWELLING FACE (Swelling of her whole face after the second dose), ERYTHEMA (Redness on her whole face after the second dose) and PRURITUS (Itching on her whole face after the second dose). On 20-Mar-2021, the patient experienced RASH (Rash on her face got really bad). At the time of the report, FATIGUE (Fatigue), SWELLING FACE (Swelling of her whole face after the second dose), ERYTHEMA (Redness on her whole face after the second dose), PRURITUS (Itching on her whole face after the second dose) and RASH (Rash on her face got really bad) outcome was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable This case was linked to MOD21-061327, MOD-2021-062562 (Patient Link).

Other Meds:

Current Illness:

ID: 1598477
Sex: F
Age: 63
State: FL

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: aches in her legs and arms; she has been experiencing fever; headache/severe headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (aches in her legs and arms), PYREXIA (she has been experiencing fever) and HEADACHE (headache/severe headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Fibromyalgia. On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (aches in her legs and arms), PYREXIA (she has been experiencing fever) and HEADACHE (headache/severe headache). At the time of the report, PAIN IN EXTREMITY (aches in her legs and arms), PYREXIA (she has been experiencing fever) and HEADACHE (headache/severe headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medications on use were not provided. No laboratory data was provided. Treatment included paracetamol.

Other Meds:

Current Illness: Fibromyalgia

ID: 1598478
Sex: U
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; Nausea; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever), NAUSEA (Nausea) and CHILLS (chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), NAUSEA (Nausea) and CHILLS (chills). At the time of the report, PYREXIA (fever), NAUSEA (Nausea) and CHILLS (chills) outcome was unknown. Not Provided No Concomitant Medications were reported.

Other Meds:

Current Illness:

ID: 1598479
Sex: F
Age:
State: UT

Vax Date: 03/08/2021
Onset Date: 03/23/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A rash across her stomach; This spontaneous case was reported by a consumer and describes the occurrence of RASH (A rash across her stomach) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Hypertension and Diabetes. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced RASH (A rash across her stomach). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, RASH (A rash across her stomach) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included unspecified high blood pressure medicine and diabetes medication.

Other Meds:

Current Illness: Diabetes; Hypertension

ID: 1598480
Sex: F
Age: 63
State:

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site reaction, cherry red circle size of a half dollar; Injection site reaction is itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site reaction, cherry red circle size of a half dollar) and VACCINATION SITE PRURITUS (Injection site reaction is itchy) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. Co-suspect product included non-company product DIAZEPAM for an unknown indication. The patient's past medical history included No adverse event. Concomitant products included INSULIN LISPRO (HUMALOG), INSULIN and BACILLUS LICHENFORMIS (ENTERAC). On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient started DIAZEPAM (unknown route) at an unspecified dose. On 15-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site reaction, cherry red circle size of a half dollar) and VACCINATION SITE PRURITUS (Injection site reaction is itchy). At the time of the report, VACCINATION SITE ERYTHEMA (injection site reaction, cherry red circle size of a half dollar) and VACCINATION SITE PRURITUS (Injection site reaction is itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: HUMALOG; INSULIN; ENTERAC

Current Illness:

ID: 1598481
Sex: M
Age: 81
State:

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feel dizzy/having dizzy spells; Sinus congestion; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feel dizzy/having dizzy spells) and SINUS CONGESTION (Sinus congestion) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The patient's past medical history included Glaucoma. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (SUDAFED OM SINUS CONGESTION) for Sinus congestion, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), MECLIZINE HCL, URSODEOXYCHOLIC ACID (URSODOL) and PANCREATIN (CREON) for an unknown indication. On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced DIZZINESS (feel dizzy/having dizzy spells). On an unknown date, the patient experienced SINUS CONGESTION (Sinus congestion). At the time of the report, DIZZINESS (feel dizzy/having dizzy spells) and SINUS CONGESTION (Sinus congestion) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Primary care gave him meclizine for dizziness. Sinus congestion was put on sudafed Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: date of birth of patient updated in followup

Other Meds: ALLEGRA; MECLIZINE HCL; URSODOL; CREON; SUDAFED OM SINUS CONGESTION

Current Illness:

ID: 1598482
Sex: F
Age: 46
State: NC

Vax Date: 02/26/2021
Onset Date: 02/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy rash that comes and goes; swelling underneath the armpit; Pain; fever; Rash generalised; Hives Generalised; Eryrhema generalised; This spontaneous case was reported by a nurse and describes the occurrence of RASH PRURITIC (itchy rash that comes and goes), URTICARIA (Hives Generalised), ERYTHEMA (Eryrhema generalised), SWELLING (swelling underneath the armpit) and PAIN (Pain) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Previously administered products included for an unreported indication: FLU VACCINE VII (Yearly) and HEPATITIS B VACCIN (13 years ago). Concurrent medical conditions included Hypothyroidism since 2017 and Type 2 diabetes mellitus. Concomitant products included SEMAGLUTIDE (OZEMPIC) and LEVOTHYROXINE for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced URTICARIA (Hives Generalised), ERYTHEMA (Eryrhema generalised) and RASH (Rash generalised). On 26-Feb-2021, the patient experienced SWELLING (swelling underneath the armpit), PAIN (Pain) and PYREXIA (fever). On 12-Mar-2021, the patient experienced RASH PRURITIC (itchy rash that comes and goes). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. On 28-Feb-2021, SWELLING (swelling underneath the armpit), PAIN (Pain) and PYREXIA (fever) had resolved. On 06-Apr-2021, URTICARIA (Hives Generalised), ERYTHEMA (Eryrhema generalised) and RASH (Rash generalised) had resolved. At the time of the report, RASH PRURITIC (itchy rash that comes and goes) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 101 (High) 101 degree F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information include steroid cream. Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Other relevant history and lab data added, Patient details added, AE Added. Outcome of event added.

Other Meds: OZEMPIC; LEVOTHYROXINE

Current Illness: Hypothyroidism; Type 2 diabetes mellitus

ID: 1598483
Sex: F
Age: 63
State: ME

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High Blood pressure 180/117 mm of Hg; Mild headache; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (High Blood pressure 180/117 mm of Hg), HEADACHE (Mild headache) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no reported medical history). Concomitant products included LANSOPRAZOLE (PREVACID), NITROFURANTOIN, ESCITALOPRAM OXALATE (LEXAPRO), ALPRAZOLAM, MELOXICAM, MONTELUKAST, ATORVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (Mild headache) and FATIGUE (Fatigue). On 08-Mar-2021, the patient experienced HYPERTENSION (High Blood pressure 180/117 mm of Hg). At the time of the report, HYPERTENSION (High Blood pressure 180/117 mm of Hg) was resolving and HEADACHE (Mild headache) and FATIGUE (Fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Blood pressure measurement: 180/117 mmHg (High) High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information included anti-hypertensive medicines.

Other Meds: PREVACID; NITROFURANTOIN; LEXAPRO; ALPRAZOLAM; MELOXICAM; MONTELUKAST; ATORVASTATIN; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1598484
Sex: M
Age: 55
State: CT

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Facial numbness on same side, lasted longer for 12 hrs; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Facial numbness on same side, lasted longer for 12 hrs) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant product use was not reported by the reporter. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced HYPOAESTHESIA (Facial numbness on same side, lasted longer for 12 hrs). On 03-Mar-2021, HYPOAESTHESIA (Facial numbness on same side, lasted longer for 12 hrs) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1598485
Sex: F
Age: 66
State: NY

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash all over body; feeling sick , not well; rash at injection site; fast heartbeat; feeling sick , not well; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED, MALAISE, ILLNESS, VACCINATION SITE RASH, and RASH in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 1030M20A and 003A21A) for an unknown indication. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced HEART RATE INCREASED, MALAISE, and VACCINATION SITE RASH. On 09-Mar-2021, the patient experienced ILLNESS. On 17-Mar-2021, the patient experienced RASH. On 11-Feb-2021, MALAISE and VACCINATION SITE RASH outcome was unknown. On 11-Mar-2021, ILLNESS outcome was unknown. At the time of the report, HEART RATE INCREASED and RASH outcome was unknown. Action taken with mRNA-1273 in response to the event was not applicable No concomitant was provided. Patient treatment information was not provided.

Other Meds:

Current Illness:

ID: 1598486
Sex: F
Age:
State: AZ

Vax Date: 03/20/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on both legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on both legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on both legs). At the time of the report, RASH (Rash on both legs) had not resolved. Not Provided Patient stated has taken allergy medication and no relief yet. Patient stated has been visiting HCP.

Other Meds:

Current Illness:

ID: 1598487
Sex: U
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Developed urticaria within an hour after; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (Developed urticaria within an hour after) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced URTICARIA (Developed urticaria within an hour after). At the time of the report, URTICARIA (Developed urticaria within an hour after) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medication was reported. NO treatment was provided for events.

Other Meds:

Current Illness:

ID: 1598488
Sex: F
Age: 46
State: WI

Vax Date: 03/13/2021
Onset Date: 03/20/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sweating; Threw up; Chills; Painful lump on right collar bone; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Painful lump on right collar bone), HYPERHIDROSIS (Sweating), VOMITING (Threw up) and CHILLS (Chills) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced MASS (Painful lump on right collar bone). On 23-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), VOMITING (Threw up) and CHILLS (Chills). At the time of the report, MASS (Painful lump on right collar bone), HYPERHIDROSIS (Sweating), VOMITING (Threw up) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1598489
Sex: F
Age:
State: UT

Vax Date: 02/16/2021
Onset Date: 03/20/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Started to get sick), HEADACHE (Really bad headache), MYALGIA (Body ache) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 031M20A) for COVID-19 vaccination. Concomitant products included VALSARTAN for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced ILLNESS (Started to get sick), HEADACHE (Really bad headache), MYALGIA (Body ache) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (Started to get sick), HEADACHE (Really bad headache), MYALGIA (Body ache) and CHILLS (Chills) outcome was unknown. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds: VALSARTAN

Current Illness:

ID: 1598490
Sex: F
Age: 33
State: TX

Vax Date: 03/24/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of maternal exposure during breast feeding (breastfeeding and received her 1st dose of the Moderna COVID-19 vaccine) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 031A21A) for COVID-19 immunization. No medical history reported. On Mar 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced maternal exposure during breast feeding (breastfeeding and received her 1st dose of the Moderna COVID-19 vaccine). At the time of the report, maternal exposure during breast feeding (breastfeeding and received her 1st dose of the Moderna COVID-19 vaccine) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.

Other Meds:

Current Illness:

ID: 1598491
Sex: F
Age: 48
State: FL

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu like symptoms with increased heart rate; Muscle ache (like coming down with bad flu); Fast heart beat (103-109); Caller >35 days from first vaccination; Fatigue; Chills; Body ache; Stuffy; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Body ache), NASAL CONGESTION (Stuffy) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Body ache), NASAL CONGESTION (Stuffy), HEADACHE (Headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Caller >35 days from first vaccination). On 12-Mar-2021, the patient experienced TACHYCARDIA (Fast heart beat (103-109)). On 15-Mar-2021, the patient experienced MYALGIA (Muscle ache (like coming down with bad flu)). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms with increased heart rate). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Body ache), NASAL CONGESTION (Stuffy), HEADACHE (Headache), MYALGIA (Muscle ache (like coming down with bad flu)) and TACHYCARDIA (Fast heart beat (103-109)) outcome was unknown. Unknown DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Heart rate: 103-109 (High) heart beating fast (103-109) for 20-30 minutes.. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date. No concomitant medications reported by investigator Water is the other treatment medication reported Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow up received on 14MAY2021, contains reporter details, additional events added Flu like symptoms and patient state that she didn't go back for 2nd dose and patient is due for 2nd dose i.e greater than 35days from first vaccination.

Other Meds:

Current Illness:

ID: 1598492
Sex: F
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: her arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm was sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (her arm was sore). At the time of the report, PAIN IN EXTREMITY (her arm was sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment. No concomitant medications were reported. Treatment information was not provided. This case was linked to MOD-2021-155051 (Patient Link).

Other Meds:

Current Illness:

ID: 1598493
Sex: F
Age: 57
State: TX

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbness on left side of her face; tingly on left side of her face; itching sensation; mouth feels crooked towards left side; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness on left side of her face), PARAESTHESIA (tingly on left side of her face), PRURITUS (itching sensation) and MOUTH INJURY (mouth feels crooked towards left side) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced HYPOAESTHESIA (numbness on left side of her face), PARAESTHESIA (tingly on left side of her face), PRURITUS (itching sensation) and MOUTH INJURY (mouth feels crooked towards left side). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (numbness on left side of her face), PARAESTHESIA (tingly on left side of her face), PRURITUS (itching sensation) and MOUTH INJURY (mouth feels crooked towards left side) outcome was unknown. Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events were not applicable.

Other Meds:

Current Illness:

ID: 1598494
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sinuses; little bit of rash; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinuses), RASH (little bit of rash), FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event in December 2020. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (sinuses), RASH (little bit of rash), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, SINUSITIS (sinuses), RASH (little bit of rash), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. Patient reported she had COVID-19 Virus back in December and she still has fatigue, headache, sinuses, little bit of rash, and she analyzed herself with long-term symptoms of COVID-19 No treatment information was reported.

Other Meds:

Current Illness:

ID: 1598495
Sex: F
Age: 56
State: CT

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tingling down my arm; Sensation like pricking needle; Tingling numbness in left front section of my head; Progressed in left side my face; Sort of numbness not feeling anything lasted several hrs or half a day; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling down my arm), PARAESTHESIA (Sensation like pricking needle), HYPOAESTHESIA (Tingling numbness in left front section of my head), PARAESTHESIA (Progressed in left side my face) and HYPOAESTHESIA (Sort of numbness not feeling anything lasted several hrs or half a day) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The patient's past medical history included Tingling and Numbness. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PARAESTHESIA (Tingling down my arm), PARAESTHESIA (Sensation like pricking needle), HYPOAESTHESIA (Tingling numbness in left front section of my head), PARAESTHESIA (Progressed in left side my face) and HYPOAESTHESIA (Sort of numbness not feeling anything lasted several hrs or half a day). On 03-Mar-2021, PARAESTHESIA (Tingling down my arm), PARAESTHESIA (Sensation like pricking needle), HYPOAESTHESIA (Tingling numbness in left front section of my head), PARAESTHESIA (Progressed in left side my face) and HYPOAESTHESIA (Sort of numbness not feeling anything lasted several hrs or half a day) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant information were not provided by the reporter. Treatment information were not provided by the reporter.

Other Meds:

Current Illness:

ID: 1598496
Sex: F
Age:
State: NJ

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Woke up with left eye pink; left eye has a little pinch of fluid; This spontaneous case was reported by a consumer and describes the occurrence of CONJUNCTIVITIS (Woke up with left eye pink) and LACRIMATION INCREASED (left eye has a little pinch of fluid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced CONJUNCTIVITIS (Woke up with left eye pink) and LACRIMATION INCREASED (left eye has a little pinch of fluid). At the time of the report, CONJUNCTIVITIS (Woke up with left eye pink) and LACRIMATION INCREASED (left eye has a little pinch of fluid) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information not provided. List of concomitant medication were not given.

Other Meds:

Current Illness:

ID: 1598497
Sex: F
Age: 46
State: CA

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HEART RATE INCREASED (Heartbeats increased ), PYREXIA (Fever), MYALGIA (Muscle ache) and CHILLS (CHILLS) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DIZZINESS (dizziness), HEART RATE INCREASED (Heartbeats increased ), PYREXIA (Fever), MYALGIA (Muscle ache) and CHILLS (CHILLS). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DIZZINESS (dizziness), HEART RATE INCREASED (Heartbeats increased ), PYREXIA (Fever), MYALGIA (Muscle ache) and CHILLS (CHILLS) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medication provided was Tylenol. No concomitant medication were provided. Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: New events were added, treatment medication was added and event out come were updated.

Other Meds:

Current Illness:

ID: 1598498
Sex: M
Age: 61
State: KY

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on stomach; Rash on left side of the body; This spontaneous case was reported by a patient and describes the occurrence of RASH (Rash on left side of the body) and RASH (Rash on stomach) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced RASH (Rash on left side of the body). On an unknown date, the patient experienced RASH (Rash on stomach). At the time of the report, RASH (Rash on left side of the body) and RASH (Rash on stomach) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. No treatment information was provided. This case was linked to MOD21-061837 (E2B Linked Report).; Sender's Comments: MOD21-061837:Link to Dose 2 with argus ID MOD-2021-056255

Other Meds:

Current Illness:

ID: 1598499
Sex: F
Age: 92
State: MA

Vax Date: 02/16/2021
Onset Date: 03/16/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red area below the injection site that goes almost to her elbow; Feels chilly; Extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red area below the injection site that goes almost to her elbow), FATIGUE (Extremely tired) and CHILLS (Feels chilly) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Extremely tired). On 19-Mar-2021, the patient experienced ERYTHEMA (Red area below the injection site that goes almost to her elbow) and CHILLS (Feels chilly). On 18-Mar-2021, FATIGUE (Extremely tired) had resolved. At the time of the report, ERYTHEMA (Red area below the injection site that goes almost to her elbow) and CHILLS (Feels chilly) outcome was unknown. The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable No concomitant medications were reported Patient used ice on erythema site and it helped Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Additional document contains no new information

Other Meds:

Current Illness:

ID: 1598500
Sex: F
Age:
State:

Vax Date: 03/22/2021
Onset Date: 03/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diarrhea; This spontaneous case was reported by a health care professional and describes the occurrence of DIARRHOEA (diarrhea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment information not provided.

Other Meds: TYLENOL

Current Illness:

ID: 1598501
Sex: F
Age: 17
State: CA

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 17 year old received dose of vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received dose of vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history was reported.). On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received dose of vaccine). On 16-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old received dose of vaccine) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of Product Administered to Patient of Inappropriate Age for mRNA-1273 (Lot number: 001B21A) with no associated AEs.

Other Meds:

Current Illness:

ID: 1598502
Sex: F
Age: 80
State: FL

Vax Date: 03/22/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: excruciating pain in arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (excruciating pain in arm) and HEADACHE (headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (excruciating pain in arm) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (excruciating pain in arm) and HEADACHE (headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1598503
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Migraine; Shortness of breath; This spontaneous case was reported by a pharmacist and describes the occurrence of MIGRAINE (Migraine) and DYSPNOEA (Shortness of breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced MIGRAINE (Migraine) and DYSPNOEA (Shortness of breath). In February 2021, MIGRAINE (Migraine) and DYSPNOEA (Shortness of breath) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1598504
Sex: U
Age:
State: WI

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: it has been 48 days since first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (it has been 48 days since first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (it has been 48 days since first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (it has been 48 days since first dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information not provided. List of concomitant medication were not given.

Other Meds:

Current Illness:

ID: 1598505
Sex: M
Age: 64
State: FL

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Low grade fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever) and FATIGUE (Fatigue) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes mellitus (Diabetes at baseline). On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Low grade fever) and FATIGUE (Fatigue). At the time of the report, PYREXIA (Low grade fever) and FATIGUE (Fatigue) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included Diabetes Medications. The patient did not received any treatment.

Other Meds:

Current Illness: Diabetes mellitus (Diabetes at baseline)

ID: 1598506
Sex: F
Age: 53
State: TX

Vax Date: 03/17/2021
Onset Date: 03/23/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: noticed swelling under her right arm pit; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE SWELLING (noticed swelling under her right arm pit) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE SWELLING (noticed swelling under her right arm pit). At the time of the report, VACCINATION SITE SWELLING (noticed swelling under her right arm pit) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information not provided. List of concomitant medication were not given.

Other Meds:

Current Illness:

ID: 1598507
Sex: F
Age: 60
State: FL

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flu like symptoms; Injection site bleeding.; Warmth at the site of the injection on left arm; Body aches/Muscle pains; Chills; Joint pains; Fatigue; Pain at the site of the injection on left arm; Redness at the site of the injection on left arm; Swelling at the site of the injection on left arm; Itching at the site of the injection on left arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE HAEMORRHAGE (Injection site bleeding.), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), MYALGIA (Body aches/Muscle pains) and CHILLS (Chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE HAEMORRHAGE (Injection site bleeding.), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), MYALGIA (Body aches/Muscle pains), CHILLS (Chills), ARTHRALGIA (Joint pains), FATIGUE (Fatigue), VACCINATION SITE PAIN (Pain at the site of the injection on left arm), VACCINATION SITE ERYTHEMA (Redness at the site of the injection on left arm), VACCINATION SITE SWELLING (Swelling at the site of the injection on left arm) and VACCINATION SITE PRURITUS (Itching at the site of the injection on left arm). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE HAEMORRHAGE (Injection site bleeding.), VACCINATION SITE WARMTH (Warmth at the site of the injection on left arm), MYALGIA (Body aches/Muscle pains), CHILLS (Chills), ARTHRALGIA (Joint pains), FATIGUE (Fatigue), VACCINATION SITE PAIN (Pain at the site of the injection on left arm), VACCINATION SITE ERYTHEMA (Redness at the site of the injection on left arm), VACCINATION SITE SWELLING (Swelling at the site of the injection on left arm) and VACCINATION SITE PRURITUS (Itching at the site of the injection on left arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. no concomitant and treatment medications were provided Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 27-Mar-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1598508
Sex: F
Age: 66
State: AZ

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Headache; Muscle Pain; Joint Pain; Nausea; fever; Swelling of lymph nodes near arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), NAUSEA (Nausea), PYREXIA (fever), LYMPHADENOPATHY (Swelling of lymph nodes near arm) and CHILLS (Chills). On 23-Mar-2021, FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle Pain), ARTHRALGIA (Joint Pain), NAUSEA (Nausea), PYREXIA (fever), LYMPHADENOPATHY (Swelling of lymph nodes near arm) and CHILLS (Chills) had resolved. Unknown The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information not provided. List of concomitant medication were not given.

Other Meds:

Current Illness:

ID: 1598509
Sex: M
Age:
State: NH

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Sore Arm; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headaches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headaches). At the time of the report, DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headaches) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided. This case was linked to US-MODERNATX, INC.-MOD-2021-042810. Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11-MAY-2021 : included No New Information; Sender's Comments: US-MODERNATX, INC.-MOD-2021-042810:sibling case (reporter)

Other Meds:

Current Illness:

ID: 1598510
Sex: F
Age:
State: CA

Vax Date: 02/27/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Got exposed to covid in school; Duration between 2 doses may exceed recommended; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got exposed to covid in school) and OFF LABEL USE (Duration between 2 doses may exceed recommended) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got exposed to covid in school) and OFF LABEL USE (Duration between 2 doses may exceed recommended). At the time of the report, COVID-19 (Got exposed to covid in school) and OFF LABEL USE (Duration between 2 doses may exceed recommended) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1598511
Sex: M
Age: 75
State: NJ

Vax Date: 01/27/2021
Onset Date: 02/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (Low grade temperature) and NAUSEA (Nausea) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 032L20A) for COVID-19 vaccination. The patient's past medical history included Migraine. Concurrent medical conditions included Diabetes and High cholesterol. Concomitant products included IBUPROFEN for Pyrexia and Nausea, FOLIC ACID for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PYREXIA (Low grade temperature) and NAUSEA (Nausea). At the time of the report, PYREXIA (Low grade temperature) and NAUSEA (Nausea) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concurrent product included medication for cholesterol. The action taken with mRNA-1273 in response to the event was not applicable. This case was linked to MOD21-084754, MOD21-040476 (E2B Linked Report). This case was linked to MOD-2021-028092. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow-up document was received. Reporter's address and email id were added. It contains non significant information.; Sender's Comments: MOD21-084754:follow up - contact information updated - last name , email , address of the reporter MOD21-040476:cross linked id

Other Meds: FOLIC ACID; IBUPROFEN

Current Illness: Diabetes; High cholesterol

ID: 1598512
Sex: M
Age: 79
State: FL

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Got tested for antibodies and he has none; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST (Got tested for antibodies and he has none) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L02A) for COVID-19 vaccination. The patient's past medical history included Kidney transplant. Concomitant products included ANTIVIRALS for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST (Got tested for antibodies and he has none). At the time of the report, ANTIBODY TEST (Got tested for antibodies and he has none) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment were provided.

Other Meds: ANTIVIRALS

Current Illness:

ID: 1598513
Sex: F
Age: 45
State: CA

Vax Date: 03/03/2021
Onset Date: 03/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: developed vertigo; inner ear infection; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (developed vertigo) and LABYRINTHITIS (inner ear infection) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VERTIGO (developed vertigo) and LABYRINTHITIS (inner ear infection). The patient was treated with AMOXICILLIN at an unspecified dose and frequency. At the time of the report, VERTIGO (developed vertigo) and LABYRINTHITIS (inner ear infection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were provided.

Other Meds:

Current Illness:

ID: 1598514
Sex: F
Age: 57
State: IL

Vax Date: 03/13/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slept for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Slept for 24 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in September 2020. Concomitant products included ZOLPIDEM TARTRATE (AMBIEN CR) for an unknown indication. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Slept for 24 hours). At the time of the report, SOMNOLENCE (Slept for 24 hours) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient stated that her arthritis pain has improved, she states she is used to have joint, knee, elbow, shoulder pain, but after taking the vaccine she got relaxed from the pain. Treatment details not included. This case was linked to MOD21-061217 (Patient Link).

Other Meds: AMBIEN CR

Current Illness:

ID: 1598515
Sex: F
Age: 65
State: AL

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced DIZZINESS (dizzy). On 24-Feb-2021, DIZZINESS (dizzy) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information not provided. List of concomitant medication were not given.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 652,500

Page last modified: 03 October 2021 5:28pm